CLINICAL_TRIALS
trial_result
· 2017-05-12
Clinical Trial Update: Lenalidomide Maintenance Therapy for Multiple Myeloma [Phase 2]
Summary
Phase 2 clinical trial update on lenalidomide maintenance therapy for multiple myeloma; the study status is terminated with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2017-05-12